Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true?

Articolo

Data di Pubblicazione:

2022

Citazione:

Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true? / Guidotti, L.G., La Vecchia, C., Colombo, M.. - In: HEPATOLOGY. - ISSN 1527-3350. - 76:2(2022), pp. 300-302. [Epub ahead of print] [10.1002/hep.32445]

Tipologia CRIS:

1.1 Articolo in rivista

Keywords:

Aspirin; Hepatitis B virus; Humans; Liver Cirrhosis; Risk Factors; Carcinoma, Hepatocellular; Liver Neoplasms

Elenco autori: